Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Oct 25, 2021 10:00 AM - Oct 26, 2021 5:15 PM

(US Eastern Standard Time)

Real-World Evidence Conference

Translating Insights into Real-World Value.

Session 8: The Future of RWE – Emerging Trends and Opportunities to Benefit Patients and Closing Remarks

Session Chair(s)

Dorothee  Bartels, PhD, MSc

Dorothee Bartels, PhD, MSc

Chief Digital Officer

Aetion, Germany

Paul M. Coplan, DrSc, MBA, MSc, FISPE

Paul M. Coplan, DrSc, MBA, MSc, FISPE

VP, Medical Device Epidemiology & Real-World Data Analytics

Johnson & Johnson, United States

This session will explore emerging trends for the future of Real World Evidence (RWE) and the complementary value of advanced analytics. The speakers will focus on the growing role of RWE for decision making, using the approach of emulating Randomized Controlled Trials (RCTs). We will address how new sources of data can be combined with more traditional research databases to provide much richer and more informative data for conducting studies, such as Patient Generated Health Data (PGHD), omics, and imaging. The session will also address challenges in combining advanced analytics with more established designs and methods. Advances in using AI-based image analysis of tumors that will facilitate the inclusion of AI-analyzed tumor images into classical RWE databases with be reviewed. Finally, the topic of how the UK researchers have been able to include genomic data into EHR databases for the purposes of RWE studies will be discussed.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify the complementary value of RWE to clinical trials
  • Envision new RWD sources for RWE generation and understand their challenges and opportunities
  • Evaluate some of the opportunities and risks when including ML/AI in their RWE research

Speaker(s)

William  Marks, MD, MS

Speaker

William Marks, MD, MS

Verily Life Sciences, United States

Head of Clinical Science & Head of Neurology

Sebastian  Schneeweiss, DrSc, MD

Speaker

Sebastian Schneeweiss, DrSc, MD

Harvard Medical School and Brigham and Women's Hospital, United States

Professor, Medicine and Epidemiology; Chief of the Div of Pharmacoepidemiology

Pallavi  Tiwari, PhD

Speaker

Pallavi Tiwari, PhD

Case Western Reserve University , United States

Assistant Professor of Biomedical Engineering, School of Medicine

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.